EPISODE · Apr 15, 2021 · 46 MIN
#188 The Story of AliveCor with Dr David Albert MD 📈
from The Healthtech Podcast · host Dr. James Somauroo
David E. Albert, MD, is the founder and Chief Medical Officer of AliveCor, the global leader in FDA-cleared personal ECG. Dr. Albert is an Oklahoma native and a physician, inventor and serial entrepreneur who has developed life-saving technologies and products over the last 30 years, turning a number of those innovations into tech startups. Today, he is a founder of three technology companies, InnovAlarm, Lifetone Technology, and AliveCor. His previous startups include Corazonix Corp (sold to Arrhythmia Research Technology) and Data Critical (sold to GE). Dr. Albert left GE in 2004 as Chief Scientist of GE Cardiology to disrupt several new markets. Get in Touch with David: www.alivecor.com YouTube Video: https://www.youtube.com/watch?v=d5Pip8qLfPs Subscribe to Healthtech Pigeon 🐦: www.healthtechpigeon.com Get in touch: www.jamessomauroo.com | www.somx.co.uk
What this episode covers
David E. Albert, MD, is the founder and Chief Medical Officer of AliveCor, the global leader in FDA-cleared personal ECG. Dr. Albert is an Oklahoma native and a physician, inventor and serial entrepreneur who has developed life-saving technologies and products over the last 30 years, turning a number of those innovations into tech startups. Today, he is a founder of three technology companies, InnovAlarm, Lifetone Technology, and AliveCor. His previous startups include Corazonix Corp (sold to Arrhythmia Research Technology) and Data Critical (sold to GE). Dr. Albert left GE in 2004 as Chief Scientist of GE Cardiology to disrupt several new markets. Get in Touch with David: www.alivecor.com YouTube Video: https://www.youtube.com/watch?v=d5Pip8qLfPs Subscribe to Healthtech Pigeon 🐦: www.healthtechpigeon.com Get in touch: www.jamessomauroo.com | www.somx.co.uk
NOW PLAYING
#188 The Story of AliveCor with Dr David Albert MD 📈
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m